These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16236508)

  • 1. 3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors.
    Weide T; Arve L; Prinz H; Waldmann H; Kessler H
    Bioorg Med Chem Lett; 2006 Jan; 16(1):59-63. PubMed ID: 16236508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second generation 4-(4-methyl-1H-indol-5-ylamino)-2-phenylthieno[2,3-b]pyridine-5-carbonitrile PKCtheta inhibitors.
    Wu B; Boschelli DH; Lee J; Yang X; Chaudhary D
    Bioorg Med Chem Lett; 2009 Feb; 19(3):766-9. PubMed ID: 19111463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors.
    Van Goethem S; Van der Veken P; Dubois V; Soroka A; Lambeir AM; Chen X; Haemers A; Scharpé S; De Meester I; Augustyns K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4159-62. PubMed ID: 18556198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.
    Van der Veken P; De Meester I; Dubois V; Soroka A; Van Goethem S; Maes MB; Brandt I; Lambeir AM; Chen X; Haemers A; Scharpé S; Augustyns K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4154-8. PubMed ID: 18556199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indole RSK inhibitors. Part 1: discovery and initial SAR.
    Boyer SJ; Burke J; Guo X; Kirrane TM; Snow RJ; Zhang Y; Sarko C; Soleymanzadeh L; Swinamer A; Westbrook J; Dicapua F; Padyana A; Cogan D; Gao A; Xiong Z; Madwed JB; Kashem M; Kugler S; O'Neill MM
    Bioorg Med Chem Lett; 2012 Jan; 22(1):733-7. PubMed ID: 22100312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis.
    Gundersen LL; Charnock C; Negussie AH; Rise F; Teklu S
    Eur J Pharm Sci; 2007 Jan; 30(1):26-35. PubMed ID: 17079120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel class of succinyl-nitrile-based Cathepsin S inhibitors.
    Bekkali Y; Thomson DS; Betageri R; Emmanuel MJ; Hao MH; Hickey E; Liu W; Patel U; Ward YD; Young ER; Nelson R; Kukulka A; Brown ML; Crane K; White D; Freeman DM; Labadia ME; Wildeson J; Spero DM
    Bioorg Med Chem Lett; 2007 May; 17(9):2465-9. PubMed ID: 17379516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives.
    Jørgensen AS; Jacobsen P; Christiansen LB; Bury PS; Kanstrup A; Thorpe SM; Naerum L; Wassermann K
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2383-6. PubMed ID: 11055361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth.
    Chollet A; Mori G; Menendez C; Rodriguez F; Fabing I; Pasca MR; Madacki J; Korduláková J; Constant P; Quémard A; Bernardes-Génisson V; Lherbet C; Baltas M
    Eur J Med Chem; 2015 Aug; 101():218-35. PubMed ID: 26142487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro biological evaluation of ring B abeo-sterols as novel inhibitors of Mycobacterium tuberculosis.
    Wei X; Rodríguez AD; Wang Y; Franzblau SG
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5448-50. PubMed ID: 18818073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design.
    Cook BN; Bentzien J; White A; Nemoto PA; Wang J; Man CC; Soleymanzadeh F; Khine HH; Kashem MA; Kugler SZ; Wolak JP; Roth GP; De Lombaert S; Pullen SS; Takahashi H
    Bioorg Med Chem Lett; 2009 Feb; 19(3):773-7. PubMed ID: 19111460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
    Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
    J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII
    Olaru AM; Vasilache V; Danac R; Mangalagiu II
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1291-1298. PubMed ID: 29072097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling.
    Zheng M; Zheng M; Ye D; Deng Y; Qiu S; Luo X; Chen K; Liu H; Jiang H
    Bioorg Med Chem Lett; 2007 May; 17(9):2414-20. PubMed ID: 17336065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase.
    Dumea C; Belei D; Ghinet A; Dubois J; Farce A; Bîcu E
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5777-5781. PubMed ID: 25453818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity.
    Kirrane TM; Boyer SJ; Burke J; Guo X; Snow RJ; Soleymanzadeh L; Swinamer A; Zhang Y; Madwed JB; Kashem M; Kugler S; O'Neill MM
    Bioorg Med Chem Lett; 2012 Jan; 22(1):738-42. PubMed ID: 22056746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycobacterial activity of 1-substituted indolizines.
    Gundersen LL; Negussie AH; Rise F; ØStby OB
    Arch Pharm (Weinheim); 2003 Jun; 336(3):191-5. PubMed ID: 12822185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors.
    Shafer CM; Lindvall M; Bellamacina C; Gesner TG; Yabannavar A; Jia W; Lin S; Walter A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4482-5. PubMed ID: 18672368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
    Park H; Bahn YJ; Ryu SE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H; Li M; Choi J; Cho H; Ham SW
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.